Company: BDRX
Filing Date: 2025-01-21
Form Type: 424B3
Source: 0001214659-25-000936
Chunk: 55

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-01-21
Form: 424B3
Chunk 55
---
 all of the Securities covered thereby have been resold or (ii) the Company supersedes one registration statement
with another registration statement, including (without limitation) by terminating a prior registration statement when it is effectively
replaced with a new registration statement covering Securities (provided in the case of this clause (ii) that all of the Securities covered
by the superseded (or terminated) registration statement that have not theretofore been resold are included in the superseding (or new)
registration statement);

(b) the
suspension of the Depositary Shares from trading on the Principal Market for a period of one (1) Business Day (other than in connection
with a general suspension of trading of all securities on the Principal Market), provided that the Company may not direct the Investor
to purchase any shares of Depositary Shares during any such suspension;

(c) the
delisting of the Depositary Shares from The Nasdaq Capital Market (or any nationally recognized successor thereto), unless the Depositary
Shares are then immediately thereafter trading on The Nasdaq Global Market, The Nasdaq Global Select Market, the New York Stock Exchange,
the NYSE American, the NYSE Arca, or the OTCQX or OTCQB operated by the OTC Markets Group, Inc. (or any nationally recognized successors
thereto);

| -29- |

(d) the
failure for any reason by the Depositary to issue Purchase Shares to the Investor on the Business Days on which the Investor is entitled
to receive such Purchase Shares;

(e) the
Company breaches any representation, warranty, covenant or other term or condition under any Transaction Document if such breach would
reasonably be expected to have a Material Adverse Effect and except, in the case of a breach of a covenant which is reasonably curable,
only if such breach continues for a period of at least ten (10) consecutive Business Days;

(f) if
any Person commences a proceeding against the Company pursuant to or within the meaning of any Bankruptcy Law and such proceeding is not
dismissed;

(g) if
the Company, pursuant to or within the meaning of any Bankruptcy Law, (i) commences a voluntary case, (ii) consents to the entry of an
order for relief against it in an involuntary case, (iii) consents to the appointment of a Custodian of it or for all or substantially
all of its property, or (iv) makes a general assignment for the benefit of its creditors or is generally